Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-13-007044

Director bought 300,042 shares at an average $3.51 ($1,052,148)

From the SEC's structured data for this filing

Trades in this filing

BRADSHER NEAL C · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2013-12-26 Purchase : show line 1 in the form +69,042 $3.53 $243,718 9,091,262 D
2013-12-26 Purchase : show line 2 in the form +0 9,091,262 I
2013-12-27 Purchase : show line 3 in the form +56,000 $3.53 $197,680 9,147,262 D
2013-12-27 Purchase : show line 4 in the form +0 9,147,262 I
2013-12-30 Purchase : show line 5 in the form +175,000 $3.49 $610,750 9,322,262 D
2013-12-30 Purchase : show line 6 in the form +0 9,322,262 I
Open-market purchases · 300,042 sh · avg $3.51 · $1,052,148
Loading xslF345X03/p1441379.xml…